| Financial Year |
March 31 2023 |
| Monetary Funds |
771,415,605.05 |
| Held-for-trading Financial Assets |
178,000.00 |
| Notes Receivable |
125,321,765.44 |
| Accounts Receivable |
877,669,581.65 |
| Advances to Suppliers |
17,135,990.66 |
| Other Receivables |
34,362,179.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
337,149,433.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,582,292.34 |
| Total Current Assets |
2,331,250,423.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,905,961.33 |
| Investment Properties |
23,889,308.34 |
| Fixed Assetes |
1,771,684,928.10 |
| Under-construction Projects |
67,650,800.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,293,457.82 |
| R&D expenses |
-- |
| Goodwill |
313,242,233.56 |
| Long-Term Deferred and Prepaid Expenses |
125,163,467.66 |
| Deferred Income Tax Assets |
86,695,656.69 |
| Other Non-Current Assets |
20,739,987.49 |
| Sub-Total of Non-Current Assets |
2,543,577,427.69 |
| Total Assets |
4,874,827,850.92 |
| Short-Term Loans |
480,524,123.15 |
| Trading Financial liabilities |
128,030.38 |
| Notes Payable |
457,504,232.37 |
| Accounts Payable |
843,330,057.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,776,475.05 |
| Taxes Payable |
24,694,139.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,724,005.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
188,397,333.41 |
| Other Current Liabilities |
95,359,334.64 |
| Sub-Total of Current Liabilities |
2,169,059,725.20 |
| Long-term Loans |
512,420,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,686,850.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,292,897.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
734,212,148.86 |
| Total Liabilities |
2,903,271,874.06 |
| Paid-In Capital(Or Share Stock) |
488,410,056.00 |
| Capital Surplus |
1,471,564,545.96 |
| Surplus Reserve |
42,526,312.58 |
| LESS:Treasury Stock |
125,002,421.62 |
| Undistributed Profits |
-226,527,844.05 |
| Minority Stockholder's Interest |
320,585,327.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,650,970,648.87 |
| Owner's Equity（Stockholder's Equity） |
1,971,555,976.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,874,827,850.92 |
